LTGO-33 is a species-specific inhibitor of the voltage-gated sodium channel NaV1.8, inhibiting NaV1.8, NaV1.1-NaV1.7, and NaV1.9.LTGO-33 inhibits wild-type and multiple NaV1.8 variants associated with human pain disorders and can be used for the study of pain.hBChE-IN-2 is a low affinity Nurr1 agonist.
Molekulargewicht:
467.44
Reinheit:
97.60%
CAS Nummer:
[2834106-06-6]
Formel:
C21H17F4N3O3S
Target-Kategorie:
Sodium Channel
T84298
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten